Advertisement
The Journal of Heart and Lung Transplantation
International Society for Heart and Lung Transplantation.

The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth Adult Heart Transplantation Report—2018; Focus Theme: Multiorgan Transplantation

      The past year has been notable for the multiple celebrations and symposia around the globe commemorating the first heart transplant ever performed by Dr. Christiaan Barnard at Groote Schuur Hospital in Cape Town, South Africa, on December 3, 1967, and the first heart transplant performed in the United States by Dr. Norman Shumway at Stanford Hospital on January 6, 1968. Since then, the field of heart transplantation has grown dramatically, with steady increases in the number of heart transplants performed worldwide annually, accompanied by improvement in post-transplant survival and other favorable outcomes. Data on heart transplant donors, recipients, and clinical outcomes have been reported to the International Society for Heart and Lung Transplantation (ISHLT) International Thoracic Organ Transplant Registry (Transplant Registry) by heart transplant centers and collectives, and have been published in summary form by way of annual reports. This 35th Annual Adult Heart Transplant Report is based on data submitted to the ISHLT Thoracic Organ Transplant Registry on 141,268 heart transplants in recipients of all ages (including 126,204 adult heart transplants) through June 30, 2017. The focus theme of the 2018 annual report is multiorgan transplantation.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Heart and Lung Transplantation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Durand CM
        • Bowring MG
        • Thomas AG
        • et al.
        The drug overdose epidemic and deceased-donor transplantation in the United States: a national registry study.
        Ann Intern Med. 2018; 168: 702-711
        • Mehra MR
        • Jarcho JA
        • Cherikh W
        • et al.
        The drug-intoxication epidemic and solid-organ transplantation.
        N Engl J Med. 2018; 378: 1943-1945
        • Lund LH
        • Khush KK
        • Cherikh WS
        • et al.
        The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth adult heart transplantation report—2017; Focus theme: Allograft ischemic time.
        J Heart Lung Transplant. 2017; 36: 1037-1046
        • Ansari D
        • Lund LH
        • Stehlik J
        • et al.
        Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab.
        J Heart Lung Transplant. 2015; 34: 1283-1291
        • Briasoulis A
        • Inampudi C
        • Pala M
        • et al.
        Induction immunosuppressive therapy in cardiac transplantation: a systematic review and meta-analysis.
        Heart Fail Rev. 2018; (2018;23:641-49)
        • Andreassen AK
        • Andersson B
        • Gustafsson F
        • et al.
        Everolimus initiation with early calcineurin inhibitor withdrawal in de novo heart transplant recipients: three-year results from the randomized SCHEDULE Study.
        Am J Transplant. 2016; 16: 1238-1247
        • Eisen HJ
        • Tuzcu EM
        • Dorent R
        • et al.
        Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
        N Engl J Med. 2003; 349: 847-858
        • Keogh A
        • Richardson M
        • Ruygrok P
        • et al.
        Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial.
        Circulation. 2004; 110: 2694-2700
        • Kobashigawa JA
        • Katznelson S
        • Laks H
        • et al.
        Effect of pravastatin on outcomes after cardiac transplantation.
        N Engl J Med. 1995; 333: 621-627
        • Kobashigawa JA
        • Moriguchi JD
        • Laks H
        • et al.
        Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients.
        J Heart Lung Transplant. 2005; 24: 1736-1740
        • Dierickx D
        • Habermann TM
        Post-transplantation lymphoproliferative disorders in adults.
        N Engl J Med. 2018; 378: 549-562
        • Lund LH
        • Edwards LB
        • Dipchand AI
        • et al.
        The Registry of the International Society for Heart and Lung Transplantation: Thirty-third adult heart transplantation report—2016; Focus Theme: Primary diagnostic indications for transplant.
        J Heart Lung Transplant. 2016; 35: 1158-1169
        • Narula J
        • Bennett LE
        • DiSalvo T
        • et al.
        Outcomes in recipients of combined heart-kidney transplantation: multiorgan, same-donor transplant study of the International Society of Heart and Lung Transplantation/United Network for Organ Sharing Scientific Registry.
        Transplantation. 1997; 63: 861-867
        • Pinderski LJ
        • Kirklin JK
        • McGiffin D
        • et al.
        Multi-organ transplantation: is there a protective effect against acute and chronic rejection?.
        J Heart Lung Transplant. 2005; 24: 1828-1833